DRC

WHO says only licensed Ebola vaccine should not be widely used in DRC outbreak

The World Health Organization has released updated emergency guidance on the use of the Ervebo vaccine in the Democratic Republic of Congo, where the deadliest Ebola outbreak on record has now claimed more than 3,000 lives. The guidelines come as…

First Ebola vaccine doses arrive in Congo amid deadliest outbreak

A new Ebola vaccine targeting the Bundibugyo strain could be ready by the end of 2026, the head of the world's leading authority on vaccines has said, as the fastest-growing Ebola outbreak in history continues to devastate the Democratic Republic…

Study finds Congo-Uganda Ebola outbreak came from new animal spillover

The Ebola outbreak ravaging the Democratic Republic of Congo and Uganda originated from a fresh spillover of the virus from animals to humans, rather than a re-emergence of strains from previous outbreaks, according to a study published Monday in Nature…

Copper hits record high as Congo bans concentrate exports

Copper prices surged to fresh record highs on Thursday after Reuters reported that the Democratic Republic of Congo has banned exports of copper and cobalt concentrates, adding to a cascade of supply disruptions that have propelled the metal more than…

Study finds thousands of tons of undeclared uranium exported from Congo via cobalt shipments

Between 2,000 and 5,000 metric tons of uranium have been extracted and exported from the Democratic Republic of the Congo over the past two decades without being declared to international nuclear authorities, according to a study published Thursday in Nature…

Africa CDC prepares Ervebo vaccine trial against Bundibugyo Ebola in DRC

The Africa Centres for Disease Control and Prevention and international partners are organizing a clinical trial to test whether Merck's licensed Ervebo vaccine can protect frontline health workers against the Bundibugyo strain of Ebola in the Democratic Republic of Congo,…

First trial of Ebola antiviral begins in DRC outbreak

Researchers in the Democratic Republic of Congo began enrolling participants on July 14 in the EBO-PEP trial, the first clinical study testing Gilead Sciences' experimental antiviral obeldesivir as post-exposure prophylaxis against the Bundibugyo Ebola virus, according to ALIMA, one of…

WHO opens first clinical trial for Bundibugyo Ebola treatments in DRC

The WHO-sponsored PARTNERS clinical trial opened enrollment on Wednesday for patients in the Democratic Republic of Congo, marking the first effort to identify effective treatments for Bundibugyo virus disease amid an outbreak that has now killed more than 400 people…

Congo plans first stock exchange to tap AI mineral boom

The Democratic Republic of Congo is developing plans for its first-ever stock exchange, seeking to channel growing global appetite for critical minerals tied to artificial intelligence infrastructure into broader investment in the Central African nation's economy.

WHO releases first clinical guidelines for all Ebola and Marburg viruses

The World Health Organization on Tuesday released its first comprehensive clinical guidelines covering all major filovirus diseases, including every known species of Ebola and Marburg virus, as a fast-moving outbreak of the rare Bundibugyo strain in the Democratic Republic of…